| Literature DB >> 28546279 |
Raffaele Pesavento1, Lucia Filippi2, Antonio Palla3, Adriana Visonà4, Carlo Bova5, Marco Marzolo6, Fernando Porro7, Sabina Villalta8, Maurizio Ciammaichella9, Eugenio Bucherini10, Giovanni Nante2, Sandra Battistelli11, Maria Lorenza Muiesan12, Giampietro Beltramello13, Domenico Prisco14, Franco Casazza15, Walter Ageno16, Gualtiero Palareti17, Roberto Quintavalla18, Simonetta Monti19, Nicola Mumoli20, Nello Zanatta21, Roberto Cappelli22, Marco Cattaneo23, Valentino Moretti24, Francesco Corà25, Mario Bazzan26, Angelo Ghirarduzzi27, Anna Chiara Frigo28, Massimo Miniati14, Paolo Prandoni28.
Abstract
The impact of residual pulmonary obstruction on the outcome of patients with pulmonary embolism is uncertain.We recruited 647 consecutive symptomatic patients with a first episode of pulmonary embolism, with or without concomitant deep venous thrombosis. They received conventional anticoagulation, were assessed for residual pulmonary obstruction through perfusion lung scanning after 6 months and then were followed up for up to 3 years. Recurrent venous thromboembolism and chronic thromboembolic pulmonary hypertension were assessed according to widely accepted criteria.Residual pulmonary obstruction was detected in 324 patients (50.1%, 95% CI 46.2-54.0%). Patients with residual pulmonary obstruction were more likely to be older and to have an unprovoked episode. After a 3-year follow-up, recurrent venous thromboembolism and/or chronic thromboembolic pulmonary hypertension developed in 34 out of the 324 patients (10.5%) with residual pulmonary obstruction and in 15 out of the 323 patients (4.6%) without residual pulmonary obstruction, leading to an adjusted hazard ratio of 2.26 (95% CI 1.23-4.16).Residual pulmonary obstruction, as detected with perfusion lung scanning at 6 months after a first episode of pulmonary embolism, is an independent predictor of recurrent venous thromboembolism and/or chronic thromboembolic pulmonary hypertension.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28546279 DOI: 10.1183/13993003.01980-2016
Source DB: PubMed Journal: Eur Respir J ISSN: 0903-1936 Impact factor: 16.671